Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

阿仑膦酸钠维D3片 - NMPA Drug Approval Details

Approvals/NMPA/Alendronate Sodium and Vitamin D3 Tablets

Approved

化学药品

Alendronate Sodium and Vitamin D3 Tablets

Organon NV🇨🇳 National Medical Products Administration

Approval Date: Jan 19, 2023
Approval ID: 0a84dfd273db90e4
Company: Organon NV
Type: 化学药品

Approval Details

Approval Id: 0a84dfd273db90e4
Approval Number: 国药准字HJ20181221
Generic Name: 阿仑膦酸钠维D3片
Generic Name En: Alendronate Sodium and Vitamin D3 Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 本品含阿仑膦酸钠（以阿仑膦酸计）70mg和维生素D3 2800IU
Reg Date: 2023-01-19
Expired Date: 2028-01-18
Company Name: Organon NV
Company Detail Path: /organization/organon-nv

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 19, 2023

Approval ID

0a84dfd273db90e4

Type

化学药品

Back to NMPA Approvals